129 related articles for article (PubMed ID: 24475586)
1. Immunoreactivity for Ca 125 and INI 1 loss of expression are useful markers in the diagnosis of vulvar proximal-type epithelioid sarcomas: report of two cases.
Cossu A; Paliogiannis P; Capobianco G; Sini MC; Dessole M; Dessole S; Palmieri G
Eur J Gynaecol Oncol; 2013; 34(5):469-72. PubMed ID: 24475586
[TBL] [Abstract][Full Text] [Related]
2. Intra-articular epithelioid sarcoma showing mixed classic and proximal-type features: report of 2 cases, with immunohistochemical and molecular cytogenetic INI-1 study.
Kosemehmetoglu K; Kaygusuz G; Bahrami A; Raimondi SC; Kilicarslan K; Yildiz Y; Folpe AL
Am J Surg Pathol; 2011 Jun; 35(6):891-7. PubMed ID: 21566521
[TBL] [Abstract][Full Text] [Related]
3. A Subset of SMARCB1 (INI-1)-deficient vulvar neoplasms express germ cell markers.
Hammer PM; Kolin DL; Charville GW; McCluggage WG; Howitt BE
Histopathology; 2022 Sep; 81(3):342-351. PubMed ID: 35758187
[TBL] [Abstract][Full Text] [Related]
4. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility.
Kim HJ; Kim MH; Kwon J; Kim JY; Park K; Ro JY
Ann Diagn Pathol; 2012 Oct; 16(5):411-5. PubMed ID: 21724432
[TBL] [Abstract][Full Text] [Related]
5. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
[TBL] [Abstract][Full Text] [Related]
6. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
7. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
Le Loarer F; Zhang L; Fletcher CD; Ribeiro A; Singer S; Italiano A; Neuville A; Houlier A; Chibon F; Coindre JM; Antonescu CR
Genes Chromosomes Cancer; 2014 Jun; 53(6):475-86. PubMed ID: 24585572
[TBL] [Abstract][Full Text] [Related]
8. Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma.
Mularz K; Harazin-Lechowska A; Ambicka A; Kruczak A; Rozmus-Piętoń M; Marchińska-Osika U; Swiątkiewicz I; Król M; Pabis D; Januś G; Ryś J
Pol J Pathol; 2012 Nov; 63(3):179-83. PubMed ID: 23161234
[TBL] [Abstract][Full Text] [Related]
9. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
[TBL] [Abstract][Full Text] [Related]
10. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
Hornick JL; Dal Cin P; Fletcher CD
Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model.
Sakharpe A; Lahat G; Gulamhusein T; Liu P; Bolshakov S; Nguyen T; Zhang P; Belousov R; Young E; Xie X; Rao P; Hornick JL; Lazar AJ; Pollock RE; Lev D
Oncologist; 2011; 16(4):512-22. PubMed ID: 21357725
[TBL] [Abstract][Full Text] [Related]
12. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.
Sullivan LM; Folpe AL; Pawel BR; Judkins AR; Biegel JA
Mod Pathol; 2013 Mar; 26(3):385-92. PubMed ID: 23060122
[TBL] [Abstract][Full Text] [Related]
13. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
14. Prognostic determinants in epithelioid sarcoma.
Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
[TBL] [Abstract][Full Text] [Related]
15. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
16. INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
Orrock JM; Abbott JJ; Gibson LE; Folpe AL
Am J Dermatopathol; 2009 Apr; 31(2):152-6. PubMed ID: 19318800
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
Rekhi B; Jambhekar NA
Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
[TBL] [Abstract][Full Text] [Related]
18. A SMARCB1-deficient vulvar neoplasm with prominent myxoid stroma: report of a case showing ERG and FLI1 expression.
Tajima S; Takahasi Y; Hikoaki M; Goto R
Int J Clin Exp Pathol; 2015; 8(6):7526-32. PubMed ID: 26261664
[TBL] [Abstract][Full Text] [Related]
19. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
[TBL] [Abstract][Full Text] [Related]
20. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
Oda Y; Tsuneyoshi M
Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
